Human cross-sectional studies showed that TLR4 is involved in monocyte activation of patients with accelerated forms of atherosclerosis, and the upregulation of TLR4 on human monocyte subsets is closely associated with coronary plaque vulnerability in patients [90, 91]. This evidence concerns the gene TLR4 and atherosclerosis.